Kinggo Investment Partners
Overview
Kinggo Investment Partners is a South Korean venture capital firm established in August 2017 by Sungkyunkwan University and its alumni entrepreneurs. The firm's name, 'Kingo', is derived from 'Ginkgo biloba', the scientific name for the ginkgo tree, which symbolizes longevity and resilience. It invests in seed, early, and later-stage companies across various sectors including technology, business, finance, agribusiness, biotech, healthcare, and cleantech. The firm aims to foster the venture ecosystem in South Korea while generating returns for its investors.
Portfolio Companies
1
Website
kingo.co.krInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GPCR Therapeutics | Nov 2023 | Series C Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Kinggo Investment Partners based?
Kinggo Investment Partners is headquartered in Seoul, Seoul, South Korea.
When was Kinggo Investment Partners founded?
Founding year information for Kinggo Investment Partners is not publicly available.
How many portfolio companies does Kinggo Investment Partners have?
Kinggo Investment Partners has 1 portfolio company in Caplight's dataset.
What are some companies in Kinggo Investment Partners's portfolio?
Portfolio companies visible on Caplight include GPCR Therapeutics.
What was Kinggo Investment Partners's most recent investment shown here?
Kinggo Investment Partners's most recent investment in this portfolio sample was in GPCR Therapeutics in 2023.
What sectors does Kinggo Investment Partners focus on?
Kinggo Investment Partners focuses on Healthcare & Life Sciences.
What company stages does Kinggo Investment Partners focus on?
Kinggo Investment Partners typically invests at the Mid stage.